RTW Investments, LP 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 5,310,033 9.990% |
1,178,988 (+28.54%) |
Filing |
| 2024-02-14 07:44 am Purchase |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 4,131,045 9.300% |
260,064 (+6.72%) |
Filing |
| 2023-02-14 10:08 am Purchase |
2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,870,981 9.800% |
226,733 (+6.22%) |
Filing |
| 2022-02-14 08:07 am Purchase |
2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,644,248 9.900% |
100,000 (+2.82%) |
Filing |
| 2021-02-12 09:40 am Unchanged |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,544,248 9.890% |
0 (Unchanged) |
Filing |